← Open Payments lookup

LITAL DECOTIIS: Open Payments

NPI 1538879754 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$510 in 35 payments from 8 companies in 2025. Trend: 2023 $1,082 · 2024 $958 · 2025 $510

Food & beverage: $510
CompanyPaymentsAmount
ABBVIE INC.24$278
Janssen Biotech, Inc.3$65
Takeda Pharmaceuticals U.S.A., Inc.2$47
Gilead Sciences, Inc.2$41
Celltrion USA Inc.1$23
QOL Medical, LLC1$22
Lilly USA, LLC1$19
Organon LLC1$14

Products named: RINVOQ, TREMFYA, ENTYVIO, SKYRIZI, VIBERZI, VEGZELMA, CREON, LINZESS.

Industry payments across NY — which companies pay providers there.